AI-guided personalized drug combinations to treat relapsed lymphoma
A new study published by experts in Singapore suggests that an artificial intelligence (AI) platform that identifies patient-specific drug combinations can help those whose lymphomas have relapsed.
Dec 16, 2022
0
36